359 related articles for article (PubMed ID: 30278582)
21. The Effect of Vitamin D Supplementation on Attention-Deficit/Hyperactivity Disorder: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Gan J; Galer P; Ma D; Chen C; Xiong T
J Child Adolesc Psychopharmacol; 2019 Nov; 29(9):670-687. PubMed ID: 31368773
[No Abstract] [Full Text] [Related]
22. Systematic evidence synthesis of treatments for ADHD in children and adolescents: indirect treatment comparisons of lisdexamfetamine with methylphenidate and atomoxetine.
Roskell NS; Setyawan J; Zimovetz EA; Hodgkins P
Curr Med Res Opin; 2014 Aug; 30(8):1673-85. PubMed ID: 24627974
[TBL] [Abstract][Full Text] [Related]
23. Methylphenidate for attention-deficit/hyperactivity disorder in children and adolescents: Cochrane systematic review with meta-analyses and trial sequential analyses of randomised clinical trials.
Storebø OJ; Krogh HB; Ramstad E; Moreira-Maia CR; Holmskov M; Skoog M; Nilausen TD; Magnusson FL; Zwi M; Gillies D; Rosendal S; Groth C; Rasmussen KB; Gauci D; Kirubakaran R; Forsbøl B; Simonsen E; Gluud C
BMJ; 2015 Nov; 351():h5203. PubMed ID: 26608309
[TBL] [Abstract][Full Text] [Related]
24. A randomized controlled trial into the effects of neurofeedback, methylphenidate, and physical activity on EEG power spectra in children with ADHD.
Janssen TW; Bink M; Geladé K; van Mourik R; Maras A; Oosterlaan J
J Child Psychol Psychiatry; 2016 May; 57(5):633-44. PubMed ID: 26748531
[TBL] [Abstract][Full Text] [Related]
25. Amphetamines for attention deficit hyperactivity disorder (ADHD) in adults.
Castells X; Blanco-Silvente L; Cunill R
Cochrane Database Syst Rev; 2018 Aug; 8(8):CD007813. PubMed ID: 30091808
[TBL] [Abstract][Full Text] [Related]
26. Methylphenidate treatment of attention-deficit/hyperactivity disorder secondary to traumatic brain injury: a critical appraisal of treatment studies.
Jin C; Schachar R
CNS Spectr; 2004 Mar; 9(3):217-26. PubMed ID: 14999162
[TBL] [Abstract][Full Text] [Related]
27. A randomised, placebo-controlled, 24-week, study of low-dose extended-release methylphenidate in adults with attention-deficit/hyperactivity disorder.
Rösler M; Fischer R; Ammer R; Ose C; Retz W
Eur Arch Psychiatry Clin Neurosci; 2009 Mar; 259(2):120-9. PubMed ID: 19165529
[TBL] [Abstract][Full Text] [Related]
28. Prevalence and comorbidity of attention deficit hyperactivity disorder in Spain: study protocol for extending a systematic review with updated meta-analysis of observational studies.
Catalá-López F; Ridao M; Núñez-Beltrán A; Gènova-Maleras R; Alonso-Arroyo A; Aleixandre-Benavent R; Catalá MA; Tabarés-Seisdedos R
Syst Rev; 2019 Feb; 8(1):49. PubMed ID: 30744675
[TBL] [Abstract][Full Text] [Related]
29. Multimodal treatment in children and adolescents with attention-deficit/hyperactivity disorder: a 6-month follow-up.
Duric NS; Assmus J; Gundersen D; Duric Golos A; Elgen IB
Nord J Psychiatry; 2017 Jul; 71(5):386-394. PubMed ID: 28345387
[TBL] [Abstract][Full Text] [Related]
30. A post hoc comparison of the effects of lisdexamfetamine dimesylate and osmotic-release oral system methylphenidate on symptoms of attention-deficit hyperactivity disorder in children and adolescents.
Soutullo C; Banaschewski T; Lecendreux M; Johnson M; Zuddas A; Anderson C; Civil R; Higgins N; Bloomfield R; Squires LA; Coghill DR
CNS Drugs; 2013 Sep; 27(9):743-51. PubMed ID: 23801529
[TBL] [Abstract][Full Text] [Related]
31. Are ADHD medications under or over prescribed worldwide?: Protocol for a systematic review and meta-analysis.
Moreira-Maia CR; Massuti R; Tessari L; Campani F; Akutagava-Martins GC; Cortese S; Rohde LA
Medicine (Baltimore); 2018 Jun; 97(24):e10923. PubMed ID: 29901582
[TBL] [Abstract][Full Text] [Related]
32. Neurofeedback for Attention-Deficit/Hyperactivity Disorder: Meta-Analysis of Clinical and Neuropsychological Outcomes From Randomized Controlled Trials.
Cortese S; Ferrin M; Brandeis D; Holtmann M; Aggensteiner P; Daley D; Santosh P; Simonoff E; Stevenson J; Stringaris A; Sonuga-Barke EJ;
J Am Acad Child Adolesc Psychiatry; 2016 Jun; 55(6):444-55. PubMed ID: 27238063
[TBL] [Abstract][Full Text] [Related]
33. Personalized at-home neurofeedback compared to long-acting methylphenidate in children with ADHD: NEWROFEED, a European randomized noninferiority trial.
Purper-Ouakil D; Blasco-Fontecilla H; Ros T; Acquaviva E; Banaschewski T; Baumeister S; Bousquet E; Bussalb A; Delhaye M; Delorme R; Drechsler R; Goujon A; Häge A; Kaiser A; Mayaud L; Mechler K; Menache C; Revol O; Tagwerker F; Walitza S; Werling AM; Bioulac S; Brandeis D
J Child Psychol Psychiatry; 2022 Feb; 63(2):187-198. PubMed ID: 34165190
[TBL] [Abstract][Full Text] [Related]
34. The pharmacological and non-pharmacological treatment of attention deficit hyperactivity disorder in children and adolescents: protocol for a systematic review and network meta-analysis of randomized controlled trials.
Catalá-López F; Hutton B; Núñez-Beltrán A; Mayhew AD; Page MJ; Ridao M; Tobías A; Catalá MA; Tabarés-Seisdedos R; Moher D
Syst Rev; 2015 Feb; 4():19. PubMed ID: 25875125
[TBL] [Abstract][Full Text] [Related]
35. An Open-Label, Randomized Trial of Methylphenidate and Atomoxetine Treatment in Children with Attention-Deficit/Hyperactivity Disorder.
Shang CY; Pan YL; Lin HY; Huang LW; Gau SS
J Child Adolesc Psychopharmacol; 2015 Sep; 25(7):566-73. PubMed ID: 26222447
[TBL] [Abstract][Full Text] [Related]
36. An RCT into the effects of neurofeedback on neurocognitive functioning compared to stimulant medication and physical activity in children with ADHD.
Geladé K; Bink M; Janssen TW; van Mourik R; Maras A; Oosterlaan J
Eur Child Adolesc Psychiatry; 2017 Apr; 26(4):457-468. PubMed ID: 27665293
[TBL] [Abstract][Full Text] [Related]
37. Effects of stimulants on brain function in attention-deficit/hyperactivity disorder: a systematic review and meta-analysis.
Rubia K; Alegria AA; Cubillo AI; Smith AB; Brammer MJ; Radua J
Biol Psychiatry; 2014 Oct; 76(8):616-28. PubMed ID: 24314347
[TBL] [Abstract][Full Text] [Related]
38. Methylphenidate for attention-deficit/hyperactivity disorder in patients with Smith-Magenis syndrome: protocol for a series of N-of-1 trials.
Müller AR; Zinkstok JR; Rommelse NNJ; van de Ven PM; Roes KCB; Wijburg FA; de Rooij-Askes E; Linders C; Boot E; van Eeghen AM
Orphanet J Rare Dis; 2021 Sep; 16(1):380. PubMed ID: 34496899
[TBL] [Abstract][Full Text] [Related]
39. Are the effects of methylphenidate uncertain?
Cortese S
Ir J Psychol Med; 2018 Sep; 35(3):163-167. PubMed ID: 30124188
[TBL] [Abstract][Full Text] [Related]
40. Neurofeedback for the treatment of children and adolescents with ADHD: a randomized and controlled clinical trial using parental reports.
Duric NS; Assmus J; Gundersen D; Elgen IB
BMC Psychiatry; 2012 Aug; 12():107. PubMed ID: 22877086
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
